## Abstract ## BACKGROUND The current study was performed to investigate the efficacy of carbogen (95% oxygen [O~2~] and 5% carbon dioxide [CO~2~]) breathing during definitive radiotherapy (RT) to enhance local control. ## METHODS Between November 1996 and November 2002, 101 patients with previo
Morbidity of supraomohyoidal and modified radical neck dissection combined with radiotherapy for head and neck cancer. A prospective longitudinal study
✍ Scribed by Alexander Ahlberg; Polymnia Nikolaidis; Therese Engström; Karin Gunnarsson; Hemming Johansson; Lena Sharp; Göran Laurell
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 212 KB
- Volume
- 34
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
The purpose of this study was to show the investigated impact of supraomohyoidal neck dissection and modified radical neck dissection, both combined with radiotherapy, on cervical range of motion (CROM), mouth opening, swallowing, lymphedema, and shoulder function.
Methods
One hundred eight patients who had neck dissections and 98 patients who had non‐neck dissections were evaluated in a prospective, nonselective, longitudinal cohort study by a physiotherapist and a speech‐language pathologist (SLP) before the start of radiotherapy and up to 12 months after treatment.
Results
The incidence of shoulder disability after neck dissection was 18%. Supraomohyoidal neck dissection had no significant effect on the evaluated parameters at any time point. Modified radical neck dissection significantly reduced CROM and mouth opening 2 months after treatment, but after 12 months only cervical rotation was still significantly reduced.
Conclusion
In patients treated with external beam radiation (EBRT), modified radical neck dissection induced additional morbidity regarding CROM but not regarding mouth opening, swallowing, and lymphedema 1 year after treatment. Both modified radical neck dissection and supraomohyoidal neck dissection induced shoulder disability. © 2011 Wiley Periodicals, Inc. Head Neck, 2012
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Topical antifungal treatments are recommended but rarely used as first‐line therapy for oropharyngeal candidiasis (OPC) in patients with cancer. Miconazole Lauriad 50‐mg mucoadhesive buccal tablet (MBT) Loramyc reportedly delivered rapid and prolonged, effective concentr